Evaluating the Safety and Efficacy of Qishen Granules Among Patients With Chronic Heart Failure: Study Protocol for a Randomized Controlled Trial

NCT03027375 Phase 2 UNKNOWN

This trial will assess the efficacy and safety of QSG in CHF.

Details

Lead sponsor	Beijing University of Chinese Medicine
Phase	Phase 2
Status	UNKNOWN
Enrolment	200
Start date	2017-03-31
Completion	2018-12

Conditions

• Heart Failure
• Cardiovascular Diseases

Interventions

• Qishen Granules
• Placebo

Primary outcomes

• the reduction or percent change in the plasma N-terminal pro-B-type natriuretic peptide — 12weeks

Countries

China